{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Novo Nordisk A/S",
    "Istituto di Ricerche Farmacologiche Mario Negri IRCCS",
    "Bayer HealthCare SAS",
    "Bayer Espana AG",
    "Maastricht University",
    "University of Groningen",
    "Evotec International, GmbH",
    "Bayer AG"
  ],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 12,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Yongxin Ye"
    },
    {
      "affs": [
        1
      ],
      "name": "Martina Colombo"
    },
    {
      "affs": [
        1
      ],
      "name": "Jennifer Meessen"
    },
    {
      "affs": [
        2
      ],
      "name": "Benoit Tyl"
    },
    {
      "affs": [
        1
      ],
      "name": "Deborah Novelli"
    },
    {
      "affs": [
        3
      ],
      "name": "Negin Hajizadeh"
    },
    {
      "affs": [
        4
      ],
      "name": "Hans‐Peter Brunner‐La Rocca"
    },
    {
      "affs": [
        5
      ],
      "name": "Adriaan Voors"
    },
    {
      "affs": [
        6
      ],
      "name": "Sara Klas"
    },
    {
      "affs": [
        7
      ],
      "name": "Stephan Schwers"
    },
    {
      "affs": [
        0
      ],
      "name": "Bjarke Follin"
    },
    {
      "affs": [
        1
      ],
      "name": "Roberto Latini"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/039ymznp2at4w.bib",
  "cited_by": 0,
  "doi": null,
  "fulltext_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13675830/?tool=EBI",
  "id": "039ymznp2at4w",
  "issns": [
    "0014-2972",
    "1365-2362"
  ],
  "landing_url": "https://europepmc.org/article/PMC/PMC13675830",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13675830/pdf/?tool=EBI",
  "pmcid": "PMC13675830",
  "pmid": null,
  "published": "2026-10-01",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/039ymznp2at4w.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:18:29Z",
      "native_id": "PMC:PMC13675830",
      "source": "europepmc",
      "url": "https://europepmc.org/article/PMC/PMC13675830"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "journal-openalex:F27",
      "subfield": "general"
    }
  ],
  "title": "Why Circulating Interleukin‐6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF: A Context‐of‐Use Review",
  "title_text": "Why Circulating Interleukin‐6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF: A Context‐of‐Use Review",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:18:29Z",
  "url": "https://research.draconitic.com/paper/039ymznp2at4w",
  "venue": "European journal of clinical investigation",
  "versions": []
}